White House Announces $2.7 Billion to Boost Vaccine Production

The transcript discusses the need for $2.7 billion for vaccine production, including supplies like needles and vials, to support global distribution. It highlights concerns about the booster rollout, noting that the Biden administration aims to provide boosters by late September, though they are not yet approved by the CDC and FDA. The discussion also covers the anxieties of parents regarding vaccinating children under 12, with ongoing reviews of safety data.

What are the concerns regarding the vaccination of children under 12?

What is the current status of vaccine safety for people over 12?